Date: 2025-09-12Category: Not ApplicableState: Union GovernmentCountry: Europe
Commission Implementing Decision (EU) 2025/1779 of 11 September 2025 postponing the expiry date of the approval of azoxystrobin for use in biocidal products of product-types 7, 9 and 10 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Issued by European Commission
· Directorate-General for Health and Food Safety
**Executive Summary:**
Commission Implementing Decision (EU) 2025/1779 postpones the expiry date of the approval of azoxystrobin for use in biocidal products of product types 7, 9, and 10 from October 31, 2025, to April 30, 2028. This decision is in response to applications submitted for renewal of approval, which require full evaluation. The decision was made on September 11, 2025, in Brussels.
**Key Points / Main Content:**
* **Azoxystrobin Approval:**
* Azoxystrobin is approved for use in biocidal products of product types 7, 9, and 10 under Implementing Regulation (EU) 2018/614.
* **Expiry Date Postponement:**
* The expiry date for azoxystrobin's approval is postponed from October 31, 2025, to April 30, 2028.
* The postponement allows for the full evaluation of applications for renewal of approval.
* **Evaluation Process:**
* Denmark, as the evaluating competent authority, determined a full evaluation of the renewal applications is necessary.
* The evaluating competent authority has 365 days (with possible suspension up to 180 days) to perform the full evaluation.
* The European Chemicals Agency (ECHA) must prepare and submit an opinion on the renewal to the Commission within 270 days of receiving a recommendation from the evaluating competent authority.
* **Continued Approval:**
* After the postponement, azoxystrobin remains approved for use in biocidal products of product types 7, 9, and 10, subject to the conditions in the Annex to Implementing Regulation (EU) 2018/614.
* **Entry into Force:**
* The decision enters into force on the twentieth day following its publication in the Official Journal of the European Union.
**Impact Analysis**
* **Applicants for Renewal of Azoxystrobin Approval:**
* *Impact:* Benefit from extended time for evaluation of their renewal applications, ensuring continued market access during the evaluation period.
* *Action Required:* Potentially provide additional data if requested by the evaluating competent authority, and continue to comply with the conditions set out in the Annex to Implementing Regulation (EU) 2018/614.
* **Evaluating Competent Authority (Denmark):**
* *Impact:* Required to conduct a full evaluation of the applications for renewal of azoxystrobin approval.
* *Action Required:* Perform a full evaluation of the applications within 365 days (subject to potential suspension), and provide a recommendation to the European Chemicals Agency (ECHA).
* **European Chemicals Agency (ECHA):**
* *Impact:* Responsible for preparing and submitting an opinion to the Commission on the renewal of azoxystrobin approval.
* *Action Required:* Prepare and submit an opinion to the Commission within 270 days of receiving a recommendation from the evaluating competent authority.
* **European Commission:**
* *Impact:* Responsible for deciding whether to renew the approval of azoxystrobin.
* *Action Required:* Consider the opinion of ECHA and decide whether to renew the approval of azoxystrobin.
* **Manufacturers and Suppliers of Biocidal Products Containing Azoxystrobin:**
* *Impact:* Can continue to market and sell biocidal products containing azoxystrobin until April 30, 2028, subject to existing conditions.
* *Action Required:* Ensure continued compliance with the conditions set out in the Annex to Implementing Regulation (EU) 2018/614.
Key Entities Referenced
European Union: A political and economic union of member states located primarily in Europe.
Commission Implementing Decision EU 2025/1779: A decision by the European Commission regarding the postponement of the expiry date of the approval of azoxystrobin.
Regulation EU No 528/2012: A regulation of the European Parliament and of the Council concerning the making available on the market and use of biocidal products.
Azoxystrobin: An active substance approved for use in biocidal products of product types 7, 9, and 10.
Commission Implementing Regulation EU 2018/614: A regulation approving azoxystrobin as an active substance for use in biocidal products.
European Chemicals Agency: An agency of the European Union that prepares and submits opinions to the Commission regarding the renewal of active substance approvals.
Denmark: A country within the European Union, whose competent authority is evaluating the applications for renewal of the approval.
Ursula VON DER LEYEN: The President of the European Commission.
Official Journal EN
of the European Union L series
2025/1779 12.9.2025
COMMISSION IMPLEMENTING DECISION(EU) 2025/1779
of 11 September 2025
postponing the expiry date of the approval of azoxystrobin for use in biocidal products of product-
types 7, 9 and 10 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of
the Council
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning
the making available on the market and use of biocidal products(1), and in particular Article 14(5) thereof,
After consulting the Standing Committee on Biocidal Products,
Whereas:
(1) Azoxystrobin was approved as an active substance for use in biocidal products of product-types 7, 9 and 10 by
Commission Implementing Regulation (EU) 2018/614(2) subject to the conditions set out in the Annex to that
Regulation.
(2) The approval of azoxystrobin for use in biocidal products of product-types 7, 9 and 10 (‘the approval’) is to expire on
31 October 2025. On 25 April 2024, applications were submitted in accordance with Article 13(1) of Regulation
(EU) No 528/2012 for the renewal of the approval (‘the applications’).
(3) On 28 June 2024, the evaluating competent authority of Denmark informed the Commission that it had decided,
pursuant to Article 14(1) of Regulation (EU) No 528/2012, that a full evaluation of the applications was necessary.
Pursuant to Article 8(1) of that Regulation, the evaluating competent authority is to perform a full evaluation of the
application within 365 days of its validation.
(4) The evaluating competent authority may, as appropriate, require the applicant to provide sufficient data to carry out
the evaluation, in accordance with Article 8(2) of Regulation (EU) No 528/2012. In that event, the 365-day period is
suspended for a period that may not exceed 180 days in total unless a longer suspension is justified by the nature of
the data requested or by exceptional circumstances.
(5) Within 270 days of receipt of a recommendation from the evaluating competent authority, the European Chemicals
Agency is to prepare and submit to the Commission an opinion on renewal of the approval of the active substance
in accordance with Article 14(3) of Regulation (EU) No 528/2012.
(6) Consequently, for reasons beyond the control of the applicant, the approval is likely to expire before a decision has
been taken on its renewal. It is therefore appropriate to postpone the expiry date of the approval for a period of time
sufficient to enable the examination of the applications. Taking into account the time-limits for evaluation by the
evaluating competent authority, for preparation and submission by the European Chemicals Agency of its opinions
and the time needed for the Commission to decide whether to renew the approval, the expiry date should be
postponed to 30 April 2028.
(7) After the postponement of the expiry date of the approval, azoxystrobin remains approved for use in biocidal
products of product-types 7, 9 and 10 subject to the conditions set out in the Annex to Implementing Regulation
(EU) 2018/614,
(1) OJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528/oj.
(2) Commission Implementing Regulation (EU) 2018/614 of 20 April 2018 approving azoxystrobin as an active substance for use in
biocidal products of product-types 7, 9 and 10 (OJ L 102, 23.4.2018, p. 5, ELI: http://data.europa.eu/eli/reg_impl/2018/614/oj).
ELI: http://data.europa.eu/eli/dec_impl/2025/1779/oj 1/2EN
OJ L, 12.9.2025
HAS ADOPTED THIS DECISION:
Article 1
The expiry date of the approval of azoxystrobin for use in biocidal products of product-types 7, 9 and 10 set out in the
Annex to Implementing Regulation (EU) 2018/614, is postponed to 30 April 2028.
Article 2
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the
European Union.
Done at Brussels, 11 September 2025.
For the Commission
The President
Ursula VON DER LEYEN
2/2 ELI: http://data.europa.eu/eli/dec_impl/2025/1779/oj